Add one or two companies to compare with China Resources Pharmaceutical Group Ltd (3320)
The comparison shows each company’s latest Scope 1, 2 and 3 emissions, how they changed, its SBTi targets and its carbon credit retirements, and where it sits in its industry. Only reported figures are shown.
Similar trading companies and commercial services companies to add
- + Toyota Tsusho Corporation (8015)about 660,000 tCO₂e Scope 1 and 2 in 2025. Same size band on the SBTi registry
- + Elis SA (ELIS)about 580,000 tCO₂e Scope 1 and 2 in 2024. Same size band on the SBTi registry
- + CCL Industries Inc. (CCL.B)about 410,000 tCO₂e Scope 1 and 2 in 2024. Same size band on the SBTi registry
Scope 1 and 2 emissions
- China Resources Pharmaceutical Group Ltd (3320) reports the largest Scope 1 and 2 figure among the 24 trading companies and commercial services companies with a figure for 2023 or later.
These are absolute footprints, so they measure a company’s size as much as its efficiency. A large company can be efficient and still sit near the top.
tCO₂e, latest reported year for each company
- China Resources Pharmaceutical Group Ltd (3320)722,460 tCO₂e, 2024
- Trading companies and commercial services median46,379 tCO₂e
Scope 3 emissions
tCO₂e, latest reported year for each company
- China Resources Pharmaceutical Group Ltd (3320)Not reported
Change over time
The SBTi cross-sector pathway for 1.5°C asks for about 4.2% less each year. A change needs two reported years at most three years apart, the latest from 2023 or later.
Average change a year, compound, between the two latest reported years
- China Resources Pharmaceutical Group Ltd (3320)Not enough years reported
- SBTi 1.5°C referencedown 4.2% a year
Climate targets
China Resources Pharmaceutical Group Ltd (3320)
- Near-term target
- Committed
- Target year
- None
- Net-zero target
- None
Carbon credit retirements
Tonnes of CO₂e retired, where the company is the named beneficiary
- China Resources Pharmaceutical Group Ltd (3320)None found
Retirements come from public registries (CarbonPlan and VROD) and cover November 2024 onward, matched to companies by name, so a missing figure does not mean a company never retired credits.
Sources
China Resources Pharmaceutical Group Ltd (3320)
How the comparison works
- Each company’s figures are its latest reported year in the emissions registry, from its own filings. A gap means the company has not reported that figure; it is never filled in or estimated.
- A zero or implausibly large figure (Scope 1 and 2 above 100 million tCO₂e, or Scope 3 above 1 billion) is shown with a “figure under review” tag and never ranked.
- The industry position compares a company’s latest Scope 1 and 2 figure from 2023 or later with every other company in the same SBTi industry that has one. It is shown only when at least 10 companies report.
- Profiles Carbon3 prepared ahead of a claim are shown here but left out of industry statistics.
Need a deeper peer review for your company?
Contact us